These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 36912379)

  • 21. Longitudinal assessment of concurrent changes in left ventricular ejection fraction and left ventricular myocardial tissue characteristics after administration of cardiotoxic chemotherapies using T1-weighted and T2-weighted cardiovascular magnetic resonance.
    Jordan JH; D'Agostino RB; Hamilton CA; Vasu S; Hall ME; Kitzman DW; Thohan V; Lawrence JA; Ellis LR; Lash TL; Hundley WG
    Circ Cardiovasc Imaging; 2014 Nov; 7(6):872-9. PubMed ID: 25273568
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Ivabradine for the Prevention of Anthracycline-Induced Cardiotoxicity in Female Patients with Primarily Breast Cancer: A Prospective, Randomized, Open-Label Clinical Trial.
    Čiburienė E; Aidietienė S; Ščerbickaitė G; Sadauskienė E; Sudavičienė D; Baltruškevičienė E; Brasiūnienė B; Drobnienė M; Čelutkienė J
    Medicina (Kaunas); 2023 Dec; 59(12):. PubMed ID: 38138243
    [No Abstract]   [Full Text] [Related]  

  • 23. Variability in echocardiography and MRI for detection of cancer therapy cardiotoxicity.
    Lambert J; Lamacie M; Thampinathan B; Altaha MA; Esmaeilzadeh M; Nolan M; Fresno CU; Somerset E; Amir E; Marwick TH; Wintersperger BJ; Thavendiranathan P
    Heart; 2020 Jun; 106(11):817-823. PubMed ID: 32098808
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Monitoring of anthracycline-induced myocardial injury using serial cardiac magnetic resonance: An animal study.
    Wang R; Zhou Z; Schoepf UJ; Varga-Szemes A; Strigenz A; Wang H; Liu Y; Xu L
    Int J Cardiol; 2021 Apr; 328():111-116. PubMed ID: 33359332
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cardiovascular magnetic resonance characterisation of anthracycline cardiotoxicity in adults with normal left ventricular ejection fraction.
    Harries I; Berlot B; Ffrench-Constant N; Williams M; Liang K; De Garate E; Baritussio A; Biglino G; Plana JC; Bucciarelli-Ducci C
    Int J Cardiol; 2021 Nov; 343():180-186. PubMed ID: 34454967
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Longitudinal assessment of cardiac parameters through MRI in breast cancer patients treated with anti-HER2 therapy.
    Cheng S; Wang J; Wang Y; Qi L; Li F; Liu J; Chen J; Fan Y; Xie L
    Eur Radiol Exp; 2023 May; 7(1):22. PubMed ID: 37183212
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Superiority of left heart deformation in early anthracycline-related cardiac dysfunction detection.
    Giang M N; Nguyen H H; Vo DT; Ho Huynh Quang T; Phan DTH; Chau NH
    Open Heart; 2023 Nov; 10(2):. PubMed ID: 38011990
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Association of Epicardial Adipose Tissue With Left Ventricular Strain and MR Myocardial Perfusion in Patients With Known Coronary Artery Disease.
    Zhu J; Xie Z; Huang H; Li W; Zhuo K; Bai Z; Huang R
    J Magn Reson Imaging; 2023 Nov; 58(5):1490-1498. PubMed ID: 36794488
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Global longitudinal strain at 3 months after therapy can predict late cardiotoxicity in breast cancer.
    Liu Z; Liu M; Zhong X; Qin Y; Liang T; Luo T; Yan X; Tang Z; Wang X; Liang S; Li Q; Ruan X; He W; Huang H
    Cancer Med; 2023 Jun; 12(12):13374-13387. PubMed ID: 37183826
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Abnormalities in 3-Dimensional Left Ventricular Mechanics With Anthracycline Chemotherapy Are Associated With Systolic and Diastolic Dysfunction.
    Zhang KW; Finkelman BS; Gulati G; Narayan HK; Upshaw J; Narayan V; Plappert T; Englefield V; Smith AM; Zhang C; Hundley WG; Ky B
    JACC Cardiovasc Imaging; 2018 Aug; 11(8):1059-1068. PubMed ID: 29550306
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Long-term cardiotoxicity in germ cell cancer survivors after platinum-based chemotherapy: cardiac MR shows impaired systolic function and tissue alterations.
    Beitzen-Heineke A; Rolling CC; Seidel C; Erley J; Molwitz I; Muellerleile K; Saering D; Senftinger J; Börschel N; Engel NW; Bokemeyer C; Adam G; Tahir E; Chen H
    Eur Radiol; 2024 Jun; 34(6):4102-4112. PubMed ID: 37982836
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Anthracycline-Induced Cardiotoxicity in Breast Cancer Patients from Southern Sri Lanka: An Echocardiographic Analysis.
    Sandamali JAN; Hewawasam RP; Fernando MACSS; Jayatilaka KAPW; Madurawe RD; Sathananthan PP; Ekanayake U; Horadugoda J
    Biomed Res Int; 2020; 2020():1847159. PubMed ID: 33274195
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Native myocardial T1 time can predict development of subsequent anthracycline-induced cardiomyopathy.
    Muehlberg F; Funk S; Zange L; von Knobelsdorff-Brenkenhoff F; Blaszczyk E; Schulz A; Ghani S; Reichardt A; Reichardt P; Schulz-Menger J
    ESC Heart Fail; 2018 Aug; 5(4):620-629. PubMed ID: 29673122
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Global and regional patterns of longitudinal strain in screening for chemotherapy-induced cardiotoxicity.
    Portugal G; Moura Branco L; Galrinho A; Mota Carmo M; Timóteo AT; Feliciano J; Abreu J; Duarte Oliveira S; Batarda L; Cruz Ferreira R
    Rev Port Cardiol; 2017 Jan; 36(1):9-15. PubMed ID: 27955938
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Deformation Analysis of Myocardial Layers Detects Early Cardiac Dysfunction after Chemotherapy in Bone Marrow Transplantation Patients: A Continuous and Additive Cardiotoxicity Process.
    Paraskevaidis IA; Makavos G; Tsirigotis P; Psarogiannakopoulos P; Parissis J; Gkirkas K; Pessach I; Ikonomidis I
    J Am Soc Echocardiogr; 2017 Nov; 30(11):1091-1102. PubMed ID: 28864152
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Early detection of anthracycline- and trastuzumab-induced cardiotoxicity: value and optimal timing of serum biomarkers and echocardiographic parameters.
    Díaz-Antón B; Madurga R; Zorita B; Wasniewski S; Moreno-Arciniegas A; López-Melgar B; Ramírez Merino N; Martín-Asenjo R; Barrio P; Amado Escañuela MG; Solís J; Parra Jiménez FJ; Ciruelos E; Castellano JM; Fernández-Friera L
    ESC Heart Fail; 2022 Apr; 9(2):1127-1137. PubMed ID: 35106939
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Subclinical Anthracycline-Induced Cardiotoxicity in the Long - Term Follow-Up of Lymphoma Survivors: A Multi-Layer Speckle Tracking Analysis.
    Kang Y; Xiao F; Chen H; Wang W; Shen L; Zhao H; Shen X; Chen F; He B
    Arq Bras Cardiol; 2018 Mar; 110(3):219-228. PubMed ID: 29694546
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Assessment of global longitudinal strain at low-dose anthracycline-based chemotherapy, for the prediction of subsequent cardiotoxicity.
    Charbonnel C; Convers-Domart R; Rigaudeau S; Taksin AL; Baron N; Lambert J; Ghez S; Georges JL; Farhat H; Lambert J; Rousselot P; Livarek B
    Eur Heart J Cardiovasc Imaging; 2017 Apr; 18(4):392-401. PubMed ID: 28064155
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Myocardial dysfunction in long-term breast cancer survivors treated at ages 40-50 years.
    Jacobse JN; Steggink LC; Sonke GS; Schaapveld M; Hummel YM; Steenbruggen TG; Lefrandt JD; Nuver J; Crijns APG; Aleman BMP; van der Meer P; Gietema JA; van Leeuwen FE
    Eur J Heart Fail; 2020 Feb; 22(2):338-346. PubMed ID: 31696625
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cardiac MRI-Based Assessment of Myocardial Injury in Asymptomatic People Living With Human Immunodeficiency Virus: Correlation With nadir CD4 Count.
    Peng X; Ding H; Huo H; Zheng Y; Zhou J; Li H; Hou Y; Li X; Geng W; Shang H; Liu T
    J Magn Reson Imaging; 2023 Dec; 58(6):1815-1823. PubMed ID: 36988474
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.